http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003512010-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 1999-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003512010-A |
| titleOfInvention | Ovarian-specific genes and proteins |
| abstract | (57) [Summary]nOvarian-specific proteins O1-180, O1-184 and O1-236, polynucleotides encoding them, antibodies immunoreactive with them, and vectors and host cells containing O1-180, O1-184 or O1-236 are provided. Is done. Also provided are methods of detecting cell proliferative or degenerative disorders of ovarian origin associated with O1-180, O1-184 and O1-236. Furthermore, methods of evaluating contraceptive candidates using the proteins of the invention, and signaling pathways associated with some forms of human infertility or gynecological cancer, also using the proteins / mRNA / genes of the invention Provided are methods for screening for gene mutations in The proteins / mRNA / genes of the present invention can also be used as markers to identify primary and metastatic neoplasms of ovarian origin and as indicators of developmental abnormalities in prenatal screening methods. In addition, the protein / mRNA / gene assays of the present invention can be used in diagnostic assays to detect forms of infertility and other diseases, including germ cell tumors and polycystic ovary syndrome. The protein of the present invention can be a useful target for in vitro fertilization, or a target for increasing the number of eggs that can be removed from a donor, for example, for improving the success rate. |
| priorityDate | 1998-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.